The PAH therapy sotatercept is the first drug to target the root cause of the disease, and trials have produced promising results. But as 2023 draws to a close, are we any closer to it being made available for patients?
4 December 2023
Sotatercept, which could be approved for use next year, has produced promising results in its latest clinical trial.
15 November 2022
Imaginative Sheffield charge nurse Ian Todd has raised hundreds for the PHA UK by setting up a virtual swear jar with his friends.
21 December 2020
